Auxilio (OTCQB:AUXO +5.9%) initiated with Buy rating and $10 price target by Craig-Hallum.
Calithera Biosciences (CALA -1.3%) initiated with Outperform rating and $16 price target by Leerink Swann.
CryoPort (CYRX) initiated with Buy rating and $3.50 price target by Needham.
Loxo Oncology (LOXO +2.9%) initiated with Overweight rating and $59 price target by Morgan Stanley.
Acorda Therapeutics (ACOR -4.5%) downgraded to Neutral with a $24 price target by JPMorgan. Downgraded to Neutral with a $19 price target by Janney Capital.
Forward Pharma (FWP -2.9%) downgraded to Hold with a $24 price target by Jefferies. Downgraded to Market Perform by JMP Securities.
Mead Johnson (MJN) downgraded to Market Perform by Wells Fargo.
ReWalk Robotics (RWLK) downgraded to Underweight with a $1.50 price target by Barclays.